COVID-19 and chronic kidney disease: an updated overview of reviews

被引:106
作者
Jdiaa, Sara S. [1 ]
Mansour, Razan [2 ]
El Alayli, Abdallah [2 ]
Gautam, Archana [2 ]
Thomas, Preston [3 ]
Mustafa, Reem A. [2 ,4 ]
机构
[1] Univ Toronto, Div Nephrol, Toronto, ON, Canada
[2] Univ Kansas, Med Ctr, Dept Internal Med, Div Nephrol & Hypertens, Kansas City, KS 66103 USA
[3] Univ Kansas, Sch Med, Kansas City, KS USA
[4] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
关键词
COVID-19; SARS-CoV-2; Chronic kidney disease (CKD); Mortality; Hospitalization; RISK-FACTORS; DIALYSIS PATIENTS; MORTALITY; COMORBIDITIES; TRANSPLANT; METAANALYSIS; MULTICENTER; DYSFUNCTION; SEVERITY; OUTCOMES;
D O I
10.1007/s40620-021-01206-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Coronavirus disease (COVID-19) has resulted in the death of more than 3.5 million people worldwide. While COVID-19 mostly affects the lungs, different comorbidities can have an impact on its outcomes. We performed an overview of reviews to assess the effect of Chronic Kidney Disease (CKD) on contracting COVID-19, hospitalization, mortality, and disease severity. Methods We searched published and preprint databases. We updated the reviews by searching for primary studies published after August 2020, and prioritized reviews that are most updated and of higher quality using the AMSTAR tool. Results We included 69 systematic reviews and 66 primary studies. Twenty-eight reviews reported on the prevalence of CKD among patients with COVID-19, which ranged from 0.4 to 49.0%. One systematic review showed an increased risk of hospitalization in patients with CKD and COVID-19 (RR = 1.63, 95% CI 1.03-2.58) (Moderate certainty). Primary studies also showed a statistically significant increase of hospitalization in such patients. Thirty-seven systematic reviews assessed mortality risk in patients with CKD and COVID-19. The pooled estimates from primary studies for mortality in patients with CKD and COVID-19 showed a HR of 1.48 (95% CI 1.33-1.65) (Moderate certainty), an OR of 1.77 (95% CI 1.54-2.02) (Moderate certainty) and a RR of 1.6 (95% CI 0.88-2.92) (Low certainty). Conclusions Our review highlights the impact of CKD on the poor outcomes of COVID-19, underscoring the importance of identifying strategies to prevent COVID-19 infection among patients with CKD. [GRAPHICS] .
引用
收藏
页码:69 / 85
页数:17
相关论文
共 144 条
[81]   Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico [J].
Martos-Benitez, Frank Daniel ;
Soler-Morejon, Caridad Dios ;
Garcia-del Barco, Diana .
INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (06) :1507-1517
[82]   Predictors of mortality in patients with COVID-19-a systematic review [J].
Mehraeen, Esmaeil ;
Karimi, Amirali ;
Barzegary, Alireza ;
Vahedi, Farzin ;
Afsahi, Amir Masoud ;
Dadras, Omid ;
Moradmand-Badie, Banafsheh ;
Alinaghi, Seyed Ahmad Seyed ;
Jahanfar, Shayesteh .
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2020, 40
[83]   Risk Factors for Hospitalization and Mortality due to COVID-19 in Espirito Santo State, Brazil [J].
Menezes Soares, Rita de Cassia ;
Mattos, Larissa Rodrigues ;
Raposo, Leticia Martins .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 103 (03) :1184-1190
[84]   Clinical Features and Laboratory Examination to Identify Severe Patients with COVID-19: A Systematic Review and Meta-Analysis [J].
Meng, Yan ;
Wang, Jinpeng ;
Wen, Kaicheng ;
Da, Wacili ;
Yang, Keda ;
Zhou, Siming ;
Tao, Zhengbo ;
Liu, Hang ;
Tao, Lin .
BIOMED RESEARCH INTERNATIONAL, 2021, 2021
[85]   Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions [J].
Mesas, Arthur Eumann ;
Cavero-Redondo, Ivan ;
Alvarez-Bueno, Celia ;
Sarria Cabrera, Marcos Aparecido ;
de Andrade, Selma Maffei ;
Sequi-Dominguez, Irene ;
Martinez-Vizcaino, Vicente .
PLOS ONE, 2020, 15 (11)
[86]  
Mudatsir Mudatsir, 2020, F1000Res, V9, P1107, DOI [10.12688/f1000research.26186.2, 10.12688/f1000research.26186.1]
[87]   Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection [J].
Munblit, Daniel ;
Nekliudov, Nikita A. ;
Bugaeva, Poling ;
Blyuss, Oleg ;
Kislova, Maria ;
Listovskaya, Ekaterina ;
Gamirova, Aysylu ;
Shilthaleva, Anastasia ;
Belyaev, Vladimir ;
Timashev, Peter ;
Warner, John O. ;
Comberiati, Pasquale ;
Apfelbacher, Christian ;
Bezrukov, Evgenii ;
Politov, Mikhail E. ;
Yavorovskiy, Andrey ;
Bulanova, Ekaterina ;
Tsareva, Natalya ;
Avdeev, Sergey ;
Kapustina, Valentina A. ;
Pigolkin, Yuri, I ;
Dankwa, Emmanuelle A. ;
Kartsonaki, Christiana ;
Pritchard, Mark G. ;
Fomin, Victor ;
Svistunov, Andrey A. ;
Butnaru, Denis ;
Glybochko, Petr .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (01) :1-11
[88]   Survival in adult inpatients with COVID-19 [J].
Murillo-Zamora, E. ;
Hernandez-Suarez, C. M. .
PUBLIC HEALTH, 2021, 190 :1-3
[89]   Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events [J].
Nandy, Kunal ;
Salunke, Abhijeet ;
Pathak, Subodh Kumar ;
Pandey, Apurva ;
Doctor, Chinmay ;
Puj, Ketul ;
Sharma, Mohit ;
Jain, Abhishek ;
Warikoo, Vikas .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (05) :1017-1025
[90]   Infectious complications in chronic kidney disease [J].
Naqvi, Sakina B. ;
Collins, Allan J. .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2006, 13 (03) :199-204